| Natural products in drug discovery: advances and opportunities AG Atanasov, SB Zotchev, VM Dirsch, CT Supuran Nature reviews Drug discovery 20 (3), 200-216, 2021 | 2808 | 2021 |
| The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical … PI Gonzalez‐Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... The Journal of pathology 250 (5), 667-684, 2020 | 171 | 2020 |
| Toxicological properties of fenugreek (Trigonella foenum graecum) M Ouzir, K El Bairi, S Amzazi Food and Chemical Toxicology 96, 145-154, 2016 | 151 | 2016 |
| The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group K El Bairi, HR Haynes, E Blackley, S Fineberg, J Shear, S Turner, ... npj Breast Cancer 7 (1), 1-17, 2021 | 147 | 2021 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 1-16, 2020 | 131 | 2020 |
| Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group M Amgad, ES Stovgaard, E Balslev, J Thagaard, W Chen, S Dudgeon, ... NPJ Breast Cancer 6 (1), 1-13, 2020 | 124 | 2020 |
| Natural products against cancer angiogenesis EB Khalid, EL Ayman, H Rahman, G Abdelkarim, A Najda Tumor Biology 37 (11), 14513-14536, 2016 | 106 | 2016 |
| Repurposing anticancer drugs for the management of COVID-19 K El Bairi, D Trapani, A Petrillo, C Le Page, H Zbakh, B Daniele, ... European Journal of Cancer 141, 40-61, 2020 | 82 | 2020 |
| Anticancer potential of Trigonella foenum graecum: cellular and molecular targets K El Bairi, M Ouzir, N Agnieszka, L Khalki Biomedicine & Pharmacotherapy 90, 479-491, 2017 | 76 | 2017 |
| Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer K El Bairi, AH Kandhro, A Gouri, W Mahfoud, N Louanjli, B Saadani, ... Cellular oncology 40 (2), 105-118, 2017 | 55 | 2017 |
| Decoding colorectal cancer epigenomics K El Bairi, K Tariq, I Himri, A Jaafari, W Smaili, AH Kandhro, A Gouri, ... Cancer genetics 220, 49-76, 2018 | 47 | 2018 |
| Plasminogen activator system and breast cancer: potential role in therapy decision making and precision medicine A Gouri, A Dekaken, KE Bairi, A Aissaoui, N Laabed, M Chefrour, ... Biomarker insights 11, BMI. S33372, 2016 | 36 | 2016 |
| The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery K El Bairi, AG Atanasov, M Amrani, S Afqir Biomedicine & Pharmacotherapy 109, 2492-2498, 2019 | 33 | 2019 |
| Phytochemical, organoleptic and ferric reducing properties of essential oil and ethanolic extract from Pistacia lentiscus (L.) D Beghlal, K El Bairi, I Marmouzi, L Haddar, B Mohamed Asian Pacific Journal of Tropical Disease 6 (4), 305-310, 2016 | 33 | 2016 |
| Prediction of therapy response in ovarian cancer: Where are we now? K El Bairi, M Amrani, AH Kandhro, S Afqir Critical reviews in clinical laboratory sciences 54 (4), 233-266, 2017 | 30 | 2017 |
| The Emerging Role of Liquid Biopsy in Gastric Cancer CG Lengyel, S Hussain, D Trapani, K El Bairi, SC Altuna, A Seeber, ... Journal of Clinical Medicine 10 (10), 2108, 2021 | 29 | 2021 |
| Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials J Hudeček, L Voorwerk, M van Seijen, I Nederlof, M de Maaker, ... NPJ Breast Cancer 6 (1), 1-8, 2020 | 28 | 2020 |
| Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer O Al Jarroudi, K El Bairi, N Abda, A Zaimi, L Jaouani, H Chibani, S Afqir Biomarkers in Medicine 15 (14), 1289-1298, 2021 | 24 | 2021 |
| FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target? CG Lengyel, S Hussain, A Seeber, S Jamil Nidhamalddin, D Trapani, ... Life 12 (1), 81, 2022 | 20 | 2022 |
| Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancer K El Bairi, O Al Jarroudi, S Afqir Seminars in Cancer Biology 77, 42-55, 2021 | 16 | 2021 |
Atanas G. AtanasovPI of LBI-DHPS. Prof of IGAB-PAS. Editor-in-Chief #CRBIOTECH & #ExplorDHT. Leader of #DHPSP & #INPST在 dhps.lbg.ac.at 的电子邮件经过验证
